Bottneuro uses Samsung Technology to provide Bottneuros digital diagnostic solutions for the Diagnosis and Treatment of Alzheimer’s Disease By Wanjiku Thuku
With medical technology continuing to evolve and offer the latest solutions and treatments to patients, Samsung Electronics Switzerland has been aiding the advancement by developing its products. Samsung collaborated with Bottneuro AG, a Swiss MedTech startup dedicated to improving the diagnosis and treatment of Alzheimer’s disease and to bring an innovative and enhanced diagnostic and treatment solution to patients. Bottneuro AG has chosen Samsung Galaxy Tab S8+ Enterprise Edition hardware to store and record therapy data in the Bottneuro Solution. Powerful Therapy through Innovative Technologies Bottneuro AG’s technology identifies areas of the brain affected by the disease through 3D magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging data. Once identified, these regions can be targeted and electronically stimulated with Mia mind® neurostimulator technology. The Galaxy Tab S8+ Enterprise Edition simplifies handling the Bottneuro solution via a graphical interface. Patients who suffer from dementia often experience reduced cognitive function in the initial stages of the disease, making the need for finding a device that is easy to operate and understand imperative for Bottneuro AG. With its intuitive interface and usability, the Galaxy Tab S8+ provided the optimal hardware for the Bottneuro solution. “We were looking for a simple and reliable solution for our application. We found it with the Galaxy Tab S8+ 5G Enterprise Edition and Samsung is giving us great support in the development,” said Julius Klaas, CTO of Bottneuro AG. Seamless Solutions in a Single Galaxy Tablet